Latest filing published 16 Jun 2017 for Celldex Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -29.1%Entry US$59.25 · Close at T+365 US$42.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Karen Shoos Lipton: trading record in brief
Karen Shoos Lipton discloses dealings in Celldex Therapeutics, Inc. to SEC (Form 4). In total, 13 filings cover trades dated from 15 May 2006 to 15 June 2017.
In open-market terms, that means 1 purchase worth €8,581 on one side and 1 sale worth €318k on the other. The net balance comes to €309k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 9 share grants and 2 option exercises.
The newest entry dates from 16 June 2017: a share grant, in Celldex Therapeutics, Inc. The most recent open-market purchase was published on 16 September 2010, 5,898 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Karen Shoos Lipton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 sharesCommon Stock, par value $0.001 per shareSEC:0001179110-17-009165:0
- 10,000 sharesCommon StockSEC:0001179110-16-026299:0
- 6,500 sharesCommon StockSEC:0001179110-15-009588:0
- 2,000 sharesCommon StockSEC:0001179110-14-009845:0
- 17,728 shares@ US$8.16Common StockSEC:0001179110-13-017670:0
- 17,728 shares@ US$24.50Common StockSEC:0001179110-13-017670:1
- 2,000 sharesCommon StockSEC:0001179110-13-010636:0
- 2,000 sharesCommon StockSEC:0001179110-12-010639:0
- 2,000 sharesCommon StockSEC:0001179110-11-010020:0
- 2,000 sharesCommon StockSEC:0001179110-10-014097:0
- 3,000 shares@ US$3.74Common StockSEC:0001179110-10-013875:0Canonical exit: 15 Dec 2010 (T+90)
- 2,000 sharesCommon StockSEC:0001179110-09-017440:0
- 4,000 shares@ US$1.23Common StockSEC:0001179110-06-011154:0
13 of 13 declarations